Apr 28, 2022 04:08PM

Apr 28, 2022 04:05PM

Apr 28, 2022 04:05PM

Apr 8, 2022 01:05PM

Apr 8, 2022 01:05PM

Mar 10, 2022 07:04AM

Mar 10, 2022 07:01AM Genocea Biosciences (GNCA) Tops Q4 EPS by 1c

Mar 10, 2022 07:00AM

Mar 10, 2022 07:00AM

Mar 8, 2022 05:39PM

Mar 8, 2022 05:39PM

Mar 3, 2022 08:00AM

Mar 3, 2022 08:00AM

Jan 4, 2022 07:03AM Genocea Biosciences (GNCA) Issues Business Update

Jan 4, 2022 07:00AM

Jan 4, 2022 07:00AM

Nov 10, 2021 07:26PM

Nov 10, 2021 07:26PM

Oct 28, 2021 12:28PM

Oct 28, 2021 07:12AM

Oct 28, 2021 07:00AM Genocea Provides Third Quarter 2021 Corporate Update

Oct 28, 2021 07:00AM

Sep 28, 2021 04:30PM

Sep 28, 2021 04:30PM

Sep 13, 2021 04:53PM

Sep 13, 2021 04:52PM

Sep 7, 2021 07:40PM

Sep 7, 2021 07:40PM Genocea to Present at Upcoming Scientific and Investor Conferences

Jul 29, 2021 07:26AM

Jul 29, 2021 07:00AM

Jul 29, 2021 07:00AM

Jul 22, 2021 05:05PM

Jul 22, 2021 05:05PM

Jul 13, 2021 07:30AM

Jul 13, 2021 07:30AM Genocea Doses First Patient in Phase 1/2a TiTAN Clinical Trial for GEN-011 Neoantigen-Targeted T cell Therapy

Apr 29, 2021 07:30AM

Apr 29, 2021 07:00AM

Apr 29, 2021 07:00AM

Apr 22, 2021 04:30PM

Apr 22, 2021 04:30PM

Feb 11, 2021 07:35AM

Feb 11, 2021 07:30AM Genocea Provides Fourth Quarter 2020 Corporate Update

Feb 11, 2021 07:30AM

Feb 4, 2021 04:05PM

Feb 4, 2021 04:05PM

Oct 29, 2020 07:59AM

Oct 29, 2020 07:00AM

Oct 29, 2020 07:00AM

Oct 22, 2020 04:57PM Genocea to Host Third Quarter 2020 Corporate Update Conference Call & Webcast

Oct 22, 2020 04:57PM

1,168,522 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All